- Home
- XNCR vs QDEL Comparison
XNCR vs QDEL Comparison
Compare XNCR & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNCR | QDEL |
|---|---|---|
| Founded | 1997 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2013 | 2022 |
Fundamental Metrics
Financial Performance| Metric | XNCR | QDEL |
|---|---|---|
| Price | $16.87 | $17.41 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 4 |
| Target Price | $22.33 | ★ $28.25 |
| AVG Volume (30 Days) | 958.3K | ★ 1.7M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.36 | 45.35 |
| EPS | N/A | ★ N/A |
| Revenue | $125,576,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | $4.80 | $3.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 13.65 | N/A |
| 52 Week Low | $6.92 | $9.92 |
| 52 Week High | $18.69 | $35.58 |
Technical Indicators
Market Signals| Indicator | XNCR | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 71.16 | 58.04 |
| Support Level | $11.06 | $14.97 |
| Resistance Level | $18.69 | $17.78 |
| Average True Range (ATR) | 1.02 | 1.30 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 97.16 | 45.82 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.